To: | Glaxo Group Limited (trademarks@gsk.com) |
Subject: | U.S. Trademark Application Serial No. 88334351 - RHENFOR - 82771811 |
Sent: | October 08, 2019 09:26:28 AM |
Sent As: | ecom104@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88334351
Mark: RHENFOR
|
|
Correspondence Address: |
|
Applicant: Glaxo Group Limited
|
|
Reference/Docket No. 82771811
Correspondence Email Address: |
|
SUSPENSION NOTICE
No Response Required
Issue date: October 08, 2019
The application is suspended for the reason(s) specified below. See 37 C.F.R. §2.67; TMEP §§716 et seq.
Application suspended until disposition of duplicate registration(s). Registration maintenance documents are or were due to be filed for the duplicate registration(s). If the maintenance documents are not timely filed and accepted by the USPTO, the duplicate registration(s) will cancel and/or expire and will no longer bar registration of applicant’s mark. See 15 U.S.C. §§1058, 1059, 1141k. Action on this application is suspended for six months to await disposition of the duplicate registration(s). See 37 C.F.R. §2.67; TMEP §716.02(e).
Suspension process. The USPTO will periodically check this application to determine if it should remain suspended. See TMEP §716.04. As needed, the trademark examining attorney will issue a letter to applicant to inquire about the status of the reason for the suspension. TMEP §716.05.
No response required. Applicant may file a response, but is not required to do so.
/Christine Martin/
Examining Attorney
Law Office 104
571-272-1630
christine.martin@uspto.gov